Alternatives to DeepCure

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

AI platform for accelerating novel peptide therapeutic discovery and development.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.